PATENT CLAIM ANALYSIS

Application Number: 16301027
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["514", "254030"]

Abstract:
Provided are a preparation method for a crystalline form of the compound represented by formula (A), as well as a method for preparation thereof, a composition thereof, and an application thereof in preparing an angiotensin II receptor antagonist or an application in preparing a drug for preventing and/or treating hypertension, chronic heart failure and diabetic nephropathy.

Claim (Index 13):
The preparation method of the crystalline form according to  claim 2 , wherein a preparation method of the crystalline form III comprises one or more of the following proceedings:\n (1) adding tetrahydrofuran to the compound of the formula (A) to obtain a suspension and stirring the suspension to obtain the crystalline form III; preferably, stirring the suspension at room temperature for 12 hours to 5 days, and most preferably, stirring the suspension at room temperature for 1-3 days; and (2) placing a tetrahydrofuran saturated solution of the compound of formula (A) in a solvent atmosphere of isopropyl ether until the crystalline form III is precipitated.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 98.0
- Lexical Diversity: 1.46512
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13001715', '15740719', '13805920', '14116099', '13505360']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7798327593252322
- 35 USC 102 Novelty (BERT): 0.5356461383318556
- Combined Prediction Score: 0.7554140972258946
- Mean Citation Score: 333.132024
- Max Citation Score: 349.10037
- Similarity Product: 265.66982665894926

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test